Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

ASCO® 2023
22:44

Dana-Farber Cancer Institute

ASCO® 2023 Summary: "RCC Updates From The Recent Trials"

FEATURING Wenxin Xu, Toni Choueiri
  • 231 views
  • July 21, 2023
20:05

Dana-Farber Cancer Institute

ASCO® 2023 Summary: "Prostate Cancer Updates From The Recent Trials"

FEATURING Jacob Berchuck, Mary-Ellen Taplin
  • 178 views
  • July 21, 2023
18:57

Dana-Farber Cancer Institute

ASCO® 2023 Summary: "Bladder Cancer Updates From The Recent Trials"

FEATURING Charlene Mantia, Joaquim Bellmunt
  • 111 views
  • July 21, 2023
23:16

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients With Renal Cell Carcinoma"

FEATURING Bradley McGregor
  • 443 views
  • June 22, 2023
  • 3
12:04

Insights from 2023 ASCO® Annual Meeting

INSIGHT Study - Ripretinib vs. Sunitinib in Patients With Advanced GIST Previously Treated With Imatinib Harboring KIT exon 11 + 17 and/or 18 Mutations

FEATURING Suzanne George
  • 114 views
  • July 17, 2023
06:11

ecancer

ASCO® 2023 Insights: "Key Head & Neck Data"

FEATURING Glenn Hanna
  • 503 views
  • June 16, 2023
  • 3
01:25

Dana-Farber Cancer Institute

ASCO® 2023 Insights: "INDIGO Trial on Vorasidenib vs. Placebo in Patients With Residual or Recurrent Grade 2 Glioma With an IDH1/2 Mutation"

FEATURING Patrick Wen
  • 112 views
  • June 15, 2023
01:41

Dana-Farber Cancer Institute

ASCO® 2023 Insights: "Dose Expansion Results of the Bifunctional EGFR/TGFβ Inhibitor BCA101 + Pembro in Pts With Recurrent, mHNSCC"

FEATURING Glenn Hanna
  • 47 views
  • June 14, 2023
02:27

Dana-Farber Cancer Institute

ASCO® 2023 Insights: "Initial Chemo for Locally Advanced & Metastatic NUT Carcinoma"

FEATURING Jia Luo
  • 50 views
  • June 14, 2023
01:51

Dana-Farber Cancer Institute

ASCO® 2023 Insights: "Effect of a Telephone-Based Weight Loss Intervention on Weight at 12-Months in Women With Early BC"

FEATURING Jennifer Ligibel
  • 9 views
  • June 14, 2023
02:25

Dana-Farber Cancer Institute

ASCO® 2023 Insights: "Prognosis & Trends in Adjuvant Chemo Use for Pts With Stage IA TNBC"

FEATURING Paolo Tarantino
  • 84 views
  • June 14, 2023
  • 1
01:46

Dana-Farber Cancer Institute

ASCO® 2023 Insights: "TROPiCS-02 Final OS Analysis of Sacituzumab Govitecan in Pts With HR+/HER2- mBC"

FEATURING Sara Tolaney
  • 167 views
  • June 14, 2023
  • 1
05:00

ecancer

ASCO® 2023 Insights: "Phase 3 CONTACT-03 Study - Efficacy & Safety of Atezo + Cabo vs. Cabo Alone After Progression With Prior ICI Treatment in mRCC"

FEATURING Toni Choueiri
  • 323 views
  • June 14, 2023
  • 1
02:12

Dana-Farber Cancer Institute

ASCO® 2023 Insights: "CONTACT-03 Study: Efficacy and Safety of Atezolizumab + Cabozantinib vs. Cabozantinib Alone After Progression With Prior ICI Treatment in mRCC"

FEATURING Toni Choueiri
  • 79 views
  • June 14, 2023
02:32

Dana-Farber Cancer Institute

ASCO® 2023 Insights: "Prognostic Impact of PSA Nadir (n)≥0.1ng/mL Within 6 Months After Completion of RT for Localized PC"

FEATURING Praful Ravi
  • 112 views
  • June 14, 2023
  • 1
07:12

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Association of Host Immune Signatures With Response to IO-Based Regimens in Patients With mRCC"

FEATURING Eddy Saad
  • 79 views
  • June 12, 2023
09:44

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Long-Term Safety of Avelumab 1L Maintenance for aUC in the JAVELIN Bladder 100 Trial"

FEATURING Joaquim Bellmunt
  • 71 views
  • June 9, 2023
  • 1
09:12

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab for Advanced RCC With Variant Histology"

FEATURING Bradley McGregor
  • 689 views
  • June 8, 2023
  • 1